-logo-1200x675.png?v=20240521153233&w=240&h=240&zc=2){kind=logo}
Artelo Biosciences (NASDAQ:ARTL) Earns Buy Rating from D. Boral Capital
Artelo Biosciences (NASDAQ:ARTL – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at D. Boral Capital in a report issued on Monday,Benzinga reports. They presently have a $6.00 price objective on the stock. D. Boral Capital’s price target suggests a potential upside of 494.06% from the stock’s previous close. Separately, HC […]
Artelo Biosciences (NASDAQ:ARTL – Get Free Report)‘s stock had its “buy” rating reiterated by equities researchers at D. Boral Capital in a report issued on Monday,Benzinga reports. They presently have a $6.00 price objective on the stock. D. Boral Capital’s price target suggests a potential upside of 494.06% from the stock’s previous close. Separately, HC […]
